Tioma Therapeutics, Inc.

The 2011 start-up Arteaus Therapeutics LLC , funded by Atlas Venture and OrbiMed, has generated a return more than 16 times the original $18m the venture capital firms invested in the company now tha

Californian biotech Forty Seven Inc. has caught the attention of two of Europe's biggest immuno-oncology players, Merck KGAA and Roche , both of which have signed deals to trial their appro

Money flowed to startups around the world in 2016 at a pace similar to 2015, providing for a steady stream of new companies to fill an important part of the biopharma ecosystem, and global venture cap

Canada's Trillium Therapeutics Inc. is looking to lead the next wave in cancer immunotherapy with novel therapeutics that target the innate immune system by inhibiting the CD47 signaling pathway,